First-of-its-kind trial tests low-dose radiation to target brain inflammation in Parkinson's disease

Mayo Clinic researchers are studying whether low-dose radiation therapy can slow the progression of Parkinson's disease by targeting inflammation in areas of the brain affected by the disease. The clinical trial is the first to investigate low-dose radiation as an anti-inflammatory approach in patients with early-stage Parkinson's disease.

Read it at Medical Xpress ↗

← Front page